心血管

订阅

MedSci主页 / 所有栏目 / 心血管

NLA血脂异常管理建议要点

2015-10-22 小田 译 医学论坛网

血脂异常管理美国国家脂质协会高血脂他汀
关注

近日，美国国家脂质协会(NLA)发表了相关专家小组编写的《以患者为中心的血脂异常管理建议(第2部分)》，全文正式在线发表于《临床脂质学杂志》(Journal of Clinical Lipidology)和NLA官网。 该建议加强了以生活方式干预为血脂管理基础的重要性，新增了心血管健康所需的饮食、饮食模式的特定变化，体力活动量以及运动量的详细建议。 该建议还突出了在特殊人群中致

近日，美国国家脂质协会(NLA)发表了相关专家小组编写的《以患者为中心的血脂异常管理建议(第2部分)》，全文正式在线发表于《临床脂质学杂志》(Journal of Clinical Lipidology)和NLA官网。


该建议加强了以生活方式干预为血脂管理基础的重要性，新增了心血管健康所需的饮食、饮食模式的特定变化，体力活动量以及运动量的详细建议。

该建议还突出了在特殊人群中致动脉粥样化胆固醇水平管理的重要性，包括不同民族及种族人群各阶段(从儿童到老年，从怀孕到更年期)，以及其他与心血管风险增加有关的情况，包括HIV疾病和类风湿性关节炎人群。

此外，该建议的其他推荐内容包括以下几点。

1、 在进行生活方式干预后，对那些心血管风险增加的人群(包括HIV/AIDS和类风湿性关节炎，基于种族和人种存在风险的人群)，应选择他汀类药物治疗。

2、 少数种族及民族的肥胖、代谢综合征和糖尿病的发病率增加，需积极干预生活方式。

3、 动脉粥样硬化常在生命早期即开始并随时间进展，因此为了长期心血管健康，在较为年轻个体中降低致动脉粥样化胆固醇水平是重要的。

4、 鉴于生活方式干预和降脂药治疗依从性非常重要，因此NLA倡议：在患者每次来诊时与其讨论依从性以发现问题扫除治疗障碍;将血脂水平和脂蛋白目标持续反馈给患者;包括医生和护士等的健康管理团队帮助患者提高依从性。

5、对接受了最大耐受剂量他汀治疗后胆固醇仍控制不达标的高危患者，可考虑添加其他降脂药。

原文阅读：

Terry A. Jacobson,et al. The National Lipid Association Publishes Part Two of Its Recommendations for Patient-Centered Management of Dyslipidemia.Journal of Clinical Lipidology.2015.09.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1774539, encodeId=cd2f1e745395e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 09 00:24:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41131, encodeId=d85041131a1, content=人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Sun Oct 25 17:18:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41057, encodeId=2bb14105eb8, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41058, encodeId=ac38410580d, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253711, encodeId=73fb1253e1163, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Oct 24 00:24:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40251, encodeId=4e434025139, content=不错，看看先, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 12:54:00 CST 2015, time=2015-10-22, status=1, ipAttribution=)]
    2016-05-09 xugumin

    #血脂异常管理#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1774539, encodeId=cd2f1e745395e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 09 00:24:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41131, encodeId=d85041131a1, content=人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Sun Oct 25 17:18:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41057, encodeId=2bb14105eb8, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41058, encodeId=ac38410580d, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253711, encodeId=73fb1253e1163, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Oct 24 00:24:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40251, encodeId=4e434025139, content=不错，看看先, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 12:54:00 CST 2015, time=2015-10-22, status=1, ipAttribution=)]
    2015-10-25 fengzhigu

    人

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1774539, encodeId=cd2f1e745395e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 09 00:24:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41131, encodeId=d85041131a1, content=人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Sun Oct 25 17:18:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41057, encodeId=2bb14105eb8, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41058, encodeId=ac38410580d, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253711, encodeId=73fb1253e1163, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Oct 24 00:24:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40251, encodeId=4e434025139, content=不错，看看先, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 12:54:00 CST 2015, time=2015-10-22, status=1, ipAttribution=)]
    2015-10-25 fatalmelanie

    好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1774539, encodeId=cd2f1e745395e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 09 00:24:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41131, encodeId=d85041131a1, content=人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Sun Oct 25 17:18:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41057, encodeId=2bb14105eb8, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41058, encodeId=ac38410580d, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253711, encodeId=73fb1253e1163, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Oct 24 00:24:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40251, encodeId=4e434025139, content=不错，看看先, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 12:54:00 CST 2015, time=2015-10-22, status=1, ipAttribution=)]
    2015-10-25 fatalmelanie

    收藏了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1774539, encodeId=cd2f1e745395e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 09 00:24:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41131, encodeId=d85041131a1, content=人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Sun Oct 25 17:18:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41057, encodeId=2bb14105eb8, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41058, encodeId=ac38410580d, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253711, encodeId=73fb1253e1163, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Oct 24 00:24:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40251, encodeId=4e434025139, content=不错，看看先, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 12:54:00 CST 2015, time=2015-10-22, status=1, ipAttribution=)]
    2015-10-24 bugit

    #血脂异常#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1774539, encodeId=cd2f1e745395e, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon May 09 00:24:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41131, encodeId=d85041131a1, content=人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150904/IMG55E8DB68F05883098.jpg, createdBy=e00a1631985, createdName=fengzhigu, createdTime=Sun Oct 25 17:18:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41057, encodeId=2bb14105eb8, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41058, encodeId=ac38410580d, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 13:06:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253711, encodeId=73fb1253e1163, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Oct 24 00:24:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40251, encodeId=4e434025139, content=不错，看看先, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 12:54:00 CST 2015, time=2015-10-22, status=1, ipAttribution=)]
    2015-10-22 owlhealth

    不错，看看先

    0

相关资讯

郭艺芳：NLA血脂异常管理

新近，美国国家脂质协会(NLA)颁发了血脂异常管理建议(草案)。由于此指南性文件在2013年ACC/AHA降胆固醇治疗指南颁发后不久浮出台面，必将受到更为广泛的关注。作为美国血脂异常领域的专门学术机构，NLA专家的立场将会在该领域产生重要影晌。这一专家建议要点主要包括以下方面：1.继续强调以致动脉粥样硬化性胆固醇(非HDL-C与LDL-C)为主要干预靶点。专家组认为非HDL-C比LDL-C更适于作

绝经后女性血脂异常管理的中国专家共识

绝经后女性动脉粥样硬化性心血管疾病（atherosclerotic cardiovascular disease，ASCVD）的多种危险因素增加，是ASCVD的高风险人群。Framingham心脏研究显示，虽然年轻女性ASCVD风险低于男性，但女性绝经后ASCVD的发病率迅速增加，与同龄非绝经女性相比，冠心病发生率增加2-3倍。 女性绝经后，血脂异常的发生率明显上升，我国50岁以上女性总